Acorah Software Products - Accounts Production 16.4.675 true true false true No description of principal activity 13 November 2023 30 November 2024 30 November 2024 15277730 Mr A S Bassi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15277730 2023-11-12 15277730 2024-11-30 15277730 2023-11-13 2024-11-30 15277730 frs-bus:PrivateLimitedCompanyLtd 2023-11-13 2024-11-30 15277730 frs-bus:FilletedAccounts 2023-11-13 2024-11-30 15277730 frs-bus:Micro-entities 2023-11-13 2024-11-30 15277730 frs-bus:EntityHasNeverTraded 2023-11-13 2024-11-30 15277730 frs-bus:AuditExempt-NoAccountantsReport 2023-11-13 2024-11-30 15277730 frs-bus:Director1 2023-11-13 2024-11-30
Registered number: 15277730
Asb Pharma Ltd
Unaudited Financial Statements
For the Period 13 November 2023 to 30 November 2024
Balance Sheet
Registered number: 15277730
30 November 2024
£
Current assets 100
NET CURRENT ASSETS 100
TOTAL ASSETS LESS CURRENT LIABILITIES 100
NET ASSETS 100
CAPITAL AND RESERVES 100

Notes

1. General Information
Asb Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15277730 . The registered office is Office 1 21 Hatherton Street, Walsall, West Midlands, WS4 2LA.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr A S Bassi
Director
25/07/2025